Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

被引:34
作者
Asano, M
Hatori, C
Sawai, H
Johki, S
Inamura, N
Kayakiri, H
Satoh, S
Abe, Y
Inoue, T
Sawada, Y
Mizutani, T
Oku, T
Nakahara, K
机构
[1] Fujisawa Pharmaceut Co Ltd, Dept Pharmacol, Ibaraki, Osaka 3002698, Japan
[2] Fujisawa Pharmaceut Co Ltd, Dept Chem, Exploratory Res Labs, Ibaraki, Osaka 3002698, Japan
关键词
bradykinin; nonpeptide antagonist; nonpeptide agonist; B-2; receptor; FR165649; FR190997;
D O I
10.1038/sj.bjp.0701813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The nonpeptide bradykinin (BK) B-2 receptor antagonist, FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxyl-2-methylquinoline), and agonist, FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl) cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy)quinoline have been identified. These compounds have a common chemical structure, and the 2-pyridylmethoxy group is the only structural difference between them. 2 Both FR165649 and FR190997 displaced [H-3]-BK binding to B-2 receptors in guinea-pig ileum membranes, with an IC50 of 4.7 x 10(-10) M and 1.5 x 10(-9) M, respectively. They also displaced [H-3]-BK binding to B-2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 X 10(-9) M and 9.8 x 10(-10) M, respectively. 3 In guinea-pig isolated ileum-preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration-response curves to BK on contraction. Analysis of the data produced a nominal pA(2) value of 9.2+/-0.1 (n = 5) and a slope of 1.4+/-0.1 (n = 5). On the other hand, FR190997 induced concentration-dependent contraction of guinea-pig ilea with a pD(2) of 7.9+/-0.2 and the contraction was inhibited by a specific peptide bradykinin B-2 receptor antagonist, Hoe 140 (D-Arg-[Hyp(3), Thi(5), D-Tic(7), Oic(8)]BK) in a non-competitive manner. 4 In IMR-90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10(-7) M) of the concentration-response curves to BK on PI hydrolysis. FR190997 induced concentration-dependent PI hydrolysis in IMR-90 cells with a pD(2) of 8.4+/-0.1, and this effect was inhibited by Hoe 140. 5 These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B-2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 36 条
[1]   Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity .1. Optimization of the agonist ''Trigger'' [J].
Aquino, CJ ;
Armour, DR ;
Berman, JM ;
Birkemo, LS ;
Carr, RAE ;
Croom, DK ;
Dezube, M ;
Dougherty, RW ;
Ervin, GN ;
Grizzle, MK ;
Head, JE ;
Hirst, GC ;
James, MK ;
Johnson, MF ;
Miller, LJ ;
Queen, KL ;
Rimele, TJ ;
Smith, DN ;
Sugg, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :562-569
[2]   Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657 [J].
Aramori, I ;
Zenkoh, J ;
Morikawa, N ;
ODonnell, N ;
Asano, M ;
Nakamura, K ;
Iwami, M ;
Kojo, H ;
Notsu, Y .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :171-176
[3]   Nonpeptide mimic of Bradykinin with long-acting properties at the Bradykinin B-2 receptor [J].
Aramori, I ;
Zenkoh, J ;
Morikawa, N ;
Asano, M ;
Hatori, C ;
Sawai, H ;
Kayakiri, H ;
Satoh, S ;
Inoue, T ;
Abe, Y ;
Sawada, Y ;
Mizutani, T ;
Inamura, N ;
Nakahara, K ;
Kojo, H ;
Oku, T ;
Notsu, Y .
MOLECULAR PHARMACOLOGY, 1997, 52 (01) :16-20
[4]   The identification of an orally active, nonpeptide bradykinin B-2 receptor antagonist, FR173657 [J].
Asano, M ;
Inamura, N ;
Hatori, C ;
Sawai, H ;
Fujiwara, T ;
Katayama, A ;
Kayakiri, H ;
Satoh, S ;
Abe, Y ;
Inoue, T ;
Sawada, Y ;
Nakahara, K ;
Oku, T ;
Okuhara, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (04) :617-624
[5]   Effects of a nonpeptide bradykinin B-2 receptor antagonist, FR167344, on different in vivo animal models of inflammation [J].
Asano, M ;
Hatori, C ;
Inamura, N ;
Sawai, H ;
Hirosumi, J ;
Fujiwara, T ;
Nakahara, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (07) :1436-1440
[6]  
BAENZIGER NL, 1992, EUR J CELL BIOL, V58, P71
[7]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[8]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[10]   BRADYKININ RECEPTOR ANTAGONISTS [J].
BURCH, RM ;
FARMER, SG ;
STERANKA, LR .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (02) :237-269